COVID-19 vaccines
How do we know the COVID-19 vaccines are safe?
Scientists look for safety issues during the testing phase and continue their monitoring as shots roll out around the world. So far, the only serious warning to emerge is a rare risk of severe allergic reactions.
COVID-19 shots might be tweaked if variants get worse
The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations — and regulators are looking to flu as a blueprint if and when the shots need an update.
China urged to trace virus before promoting 'vaccine diplomacy'
Calls are growing for China to take adequate responsibility to identify the origins of the novel coronavirus, first detected in its central city of Wuhan, before trying to boost its global clout through "vaccine diplomacy."
UN: 'Concerning news' vaccines may not work against variants
The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it “concerning news” that the vaccines developed so far may be less effective against the variant first detected in South Africa.
New variants raise worry about COVID-19 virus reinfections
Evidence is mounting that having COVID-19 may not protect against getting infected again with some of the new variants. People also can get second infections with earlier versions of the coronavirus if they mounted a weak defense the first time, new research suggests.
Seven Chinese-made vaccines enter phase-3 clinical trials: official
The following are the updates on the global fight against the COVID-19 pandemic.
Why it’s hard to make vaccines and boost supplies
With demand for COVID-19 vaccines outpacing the world’s supplies, a frustrated public and policymakers want to know: How can we get more? A lot more. Right away.
COVAX announces new agreement, plans for first deliveries
COVAX, a global initiative to ensure rapid and equitable access to Covid-19 vaccines for all countries, regardless of income level, has announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine, which has already received WHO emergency use listing.
5 dead in fire at India's Covid vaccine facility
At least five people were killed in a major fire that broke out at a Covid vaccine manufacturing plant owned by the Serum Institute of India (SII) in the western state of Maharashtra's Pune city on Thursday afternoon, officials said.
20 lakh doses of Oxford vaccine reach Dhaka as gift from India
Twenty lakh doses of Covid-19 vaccine gifted by India reached Dhaka on Thursday.